Results 191 to 200 of about 149,367 (278)

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 2, Page 354-366, February 2026.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu   +9 more
wiley   +1 more source

Geometrical Designs in Volumetric Bioprinting to Study Cellular Behaviors in Engineered Constructs

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 6, 9 February 2026.
Curvature and spatial confinement guide cell behavior in volumetrically printed 3D constructs. Endothelial cells align and spread along specific geometries, while metastatic osteosarcoma cells proliferate independently of structural cues. Label‐free holographic microscopy captures real‐time, long‐term cell–material interactions, highlighting Gel‐PEG's ...
Julia Simińska‐Stanny   +3 more
wiley   +1 more source

ReCOGnAIze app to detect vascular cognitive impairment and mild cognitive impairment

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Vascular cognitive impairment (VCI), a major cause of cognitive impairment, remains underdiagnosed due to varying non‐amnestic manifestations. It is important to detect VCI at the mild cognitive impairment (MCI) stage or earlier. We aimed to develop and validate ReCOGnAIze, a tablet‐based, gamified, and interpretable app to detect
Adnan Azam Mohammed   +13 more
wiley   +1 more source

Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Choroid plexus (ChP) enlargement is a neuroimaging biomarker of neuroinflammation and neurodegeneration. However, evidence of ChP structural and perfusion alterations in long coronavirus disease (COVID) and their clinical relevance remains limited.
Huize Pang   +11 more
wiley   +1 more source

CDR and article 6

open access: yes
Develop report on Carbon Dioxide Removals, article 6 of the Paris agreement and the needed regulatory framework.
openaire   +1 more source

Amyloid‐related default mode network hyperconnectivity and longitudinal decline in network distinctiveness in preclinical Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION We investigated stage‐specific alterations in functional connectivity (FC) of the default mode network (DMN) across the Alzheimer's disease (AD) continuum and tested whether early amyloid beta (Aβ)–related changes in within‐DMN FC (DMN‐FCwithin) predicted longitudinal alterations in DMN between‐network connectivity (DMN‐FCbetween).
Woo‐Jin Cha   +16 more
wiley   +1 more source

Detecting early memory changes in preclinical Alzheimer's disease using TabCAT favorites test: Data from the European Prevention of Alzheimer's Disease (EPAD) cohort

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Sensitive memory paradigms may allow the detection of subtle memory changes associated with early Alzheimer's pathology in individuals without established clinical symptomatology. METHODS We explored the cross‐sectional association between performance on Tablet‐based Cognitive Assessment Tool (TabCAT) Favorites, a brief ...
Anna Brugulat‐Serrat   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy